Nisa Investment Advisors LLC dramatically reduced its stake in Royalty Pharma PLC, selling nearly 22,000 shares in the third quarter. The move represents a 76.6% decrease, leaving Nisa with 6,689 shares of the biopharmaceutical company’s stock, valued at $236,000.

Shares of Banco do Brasil have reached a new 52-week low, prompting major analysts like Citigroup and Goldman Sachs to downgrade the stock from “strong-buy” to “hold.” The bank also announced a dividend distribution amid the decline.